LQ5-17200-36752
2 vaccinations
2 coded responses
14 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 018 / MA
- Registered
- 2021-03-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Dose 1 — Moderna
-
2021-03-06
Registered in v-safe
-
2021-03-06
Dose 2 — Moderna
-
2021-03-06
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Abdominal painAdult check-in
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-08
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-20
- 2021-03-29
- 2021-04-03
- 2021-04-10
- 2021-04-17
- 2021-06-05
-
2021-09-04
Survey response — 6 months, dose 2MedDRA: Chest pain, Dyspnoea — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Chest pains, shortness of breathMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-04
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-10
-
2022-03-06
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, Pre-existing disease, Pruritus, Surgery — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Extreme itchiness, pregnancy loss, chronic headaches, asthma. · Healthcare visit (other): SurgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-03-06
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Moderna | |
| 2 | 2021-03-06 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-04 | Unsuccessful | |
| 2022-03-06 | Unsuccessful |
Free text
Release 9 — 6 months, dose 2
Symptoms: Chest pains, shortness of breath
Release 11 — 12 months, dose 2
Symptoms: Extreme itchiness, pregnancy loss, chronic headaches, asthma.
Healthcare visit (other): Surgery
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Surgery | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Chest pain | ✓ | · | ✓ |
| SD | Dyspnoea | ✓ | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pruritus | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release